ECOG performance score 0-3
ECOG performance-status score of 2 or less
ECOG performance status score ? 2.
Halabi Nomogram score <1951
Nottingham score of 3 (specially nuclear and mitotic score>2)
Participants with an Inventory of Depressive Symptomatology (IDS) score > 32 or IDS #18 score 2 >= will be referred to Dr. Andrew Miller
IPSS score <= 16.
Moderate cGvHD: At least one organ (not lung) with a score of 2, 3 or more organs involved with a score of 1 in each organ, or lung score of 1
Severe cGvHD: at least 1 organ with a score of 3, or lung score of 2 or 3
ECOG Score of 0-2
ECOG performance status score of 2 or less
Performance score (PS) of 0-2 by Zubrod score
ECOG score 2 or less
Patients with a biopsy-proven adult-type high-risk soft tissue sarcoma (STS) in the trunk (non-retroperitoneal) or extremities. Histologies will include the most common adult-type STS such as undifferentiated pleomorphic sarcoma, liposarcoma, leiomyosarcoma, fibrosarcoma, synovial sarcoma, angiosarcoma, epithelioid sarcoma and malignant peripheral nerve sheath tumor. STS considered high-risk as defined below:\r\n* Tumors greater than or equal to 5 cm, intermediate or high grade according to French Federation of Comprehensive Cancer Centers (FNCLCC) criteria, and a location deep or superficial to fascia\r\n* Intermediate or high-grade tumors that are locally recurrent, metastatic or have had prior inadequate resections \r\n* Intermediate and high grade tumors shall be grade 2 or 3 based on FNCLCC parameters (Trojani et al, 1984; Coindre 2006)\r\n** Tumor differentiation\r\n*** Score 1 (sarcomas closely resembling normal adult mesenchymal tissue)\r\n*** Score 2 (sarcomas for which histological typing is certain)\r\n*** Score 3 (embryonal and undifferentiated sarcomas)\r\n** Mitotic count (HPF – high power field – 0.17 mm squared)\r\n*** Score 1 (0-9 mitoses per 10 HPF)\r\n*** Score 2 (10-19 mitoses per 10 HPF)\r\n*** Score 3 (greater than or equal to 20 mitoses per 10 HPF)\r\n** Tumor necrosis\r\n*** Score 0 (no necrosis)\r\n*** Score 1 (less than 50% tumor necrosis)\r\n*** Score 2 (greater than or equal to 50% tumor necrosis)\r\n** Histological grade\r\n*** Grade 1 – total score 2 or 3\r\n*** Grade 2 – total score 4 or 5\r\n*** Grade 3 – total score 6, 7 or 8
ECOG score 2
ECOG performance score of 0 or 1 .
Geriatric assessment score of >= 2
Osteoporosis, defined as T-score less than -2.5
Patient has an ECOG Performance Status score of 0 or 1 (solid tumors) or KPS score ? 70 (rHGG).
IPSS score =< 15
IPSS score > 15
Adequate blood cell counts, kidney function, liver function and Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 (for the Recommended Phase 2 Cohort, a ECOG score of 2 may be allowed on a case-by-case basis)
Evidence of cirrhosis, documented by one of the following: Liver biopsy histologic diagnosis: Metavir Score greater than 3 (includes 3 - 4 or ¾) or Ishak score greater than 4 In the absence of liver biopsy: a FibroScan score greater than or equal to 12.5 kPa or Fibrotest score of >0.75 AND an APRI score greater than 1.5
Has an ECOG performance status score of 0 to 2.
Have an ECOG Performance Status score of 0 to 2.
Must have a baseline American Urological Association (AUA)/International Prostate Symptom Score (IPSS) score of < 20
Active symptoms of MF as demonstrated by a symptom score of at least 5 points (on a 0 to10 scale) on at least one of the symptoms or a score of 3 or greater on at least 2 of the symptoms
Subjects must have an ECOG Performance Score of 0-1.
ECOG performance status of 0-1 (score of 2 may be acceptable)
ECOG performance status of 0-1 (score of 2 may be acceptable)
ECOG Score ?2
ECOG Performance Status score of 0 or 2 for subjects with NMC; 0-1 for subjects with other tumor types.
ECOG Performance Status score of ? 1
Internation Prostate Symptom Score score must be ? 15 (alpha blockers allowed);
ECOG Performance Status score 0 or 1
Have good performance score (0-1).
Subject has a TBS with an SBSS score of 1, 2, or 3.
Any National Comprehensive Cancer Network (NCCN)-International Prognostic Index (IPI) score; a calculated score required for enrollment
Patients must have an ECOG performance score between 0 and 1.
Patients must have an ECOG Performance Score of 0 or 1.
ECOG performance score ? 1
ECOG score of 0 or 1
Patient must have proven positive tumor sample for NY-ESO-1 as determined by an H score for immunohistochemistry staining. Positive expression is defined as an H score ? 100 where the H score = [2 x (% cells 2+) + 3 x (% cells 3+)]. NOTE: The percentages of negative or weakly stained nuclei (i.e. 1+) are not to be included in the calculation of the H score.
ECOG Performance Score of 0 or 1
ECOG performance status score of 0-2.
Must have an ECOG performance status score of less than or equal to 2.
Participant must have an ECOG performance status score of 0 or 1
Patients must have an ECOG score =< 3
MMSE score 25 or above
ECOG Performance Score of 0 -2
Patient must have an ECOG Performance Score of 0, 1, or 2 (refer to Appendix II).
ECOG Performance Status score of 0, 1 or 2
Mirels Criteria Score ? 8. (specific to the target humeral lesion and subject to minimum VAS score requirements)
ECOG performance status score 0, 1 or 2
Neuropathy Impairment Score requirement of 5-130
Patients must have an ECOG performance score of 0, 1, or 2.
ECOG Performance Score of 0 or 1
Performance Status corresponding to ECOG score of 0, 1, or 2:
ECOG Performance Status score of 0 or 1
Subject has screening MOD score of ?9
ECOG performance score of 0-2.
MELD Score < 15
Patient has an Impact of Events Scale (IES) score >= 16 and/or partner has an IES score of >= 17 at the time of initial screening for eligibility
After completion of all three screening questionnaires, participant must score accordingly on at least one questionnaire to be eligible:\r\n* Score >= 8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)-Anxiety/Depression Scale OR\r\n* Score >= 4 on the Distress Thermometer OR\r\n* Score > 5 on the Modified Cancer Acceptance Scale
Have a baseline Distress Thermometer score of >= 4, or an Impact of Events Scale score of >= 9, or Center for Epidemiological Studies Depression Scale score of >= 16 (i.e. clinically meaningful thresholds)
Either a score of > 15 on the Brief Penn State Worry Questionnaire OR a score >= 12 on the Brooding Subscale of the Rumination Response Scale
Minimum pre-treatment oNCF score >= 70
ECOG score of 0,1,or 2 OR Karnofsky score of 50 or higher
WHO/ECOG performance score > 2 and life expectancy of < 6 months
Score at least a 5 on the Contemplation Ladder
ECOG Performance Score of 0 or 1 within 14 days prior to registration
Have an ECOG score of 0-1